100 Examples of sentences containing the common noun "tga therapeutic-goods-administration"

Definition

TGA (Therapeutic Goods Administration) refers to the regulatory authority in Australia responsible for overseeing the safety, efficacy, and quality of therapeutic goods including medicines, medical devices, and biological products. The TGA ensures that these goods meet the necessary standards before they can be marketed and sold to the public.

Synonyms

• Australian Therapeutic Goods Administration
• Regulatory authority for therapeutic goods
• Medicines and Medical Devices Regulatory Agency

Antonyms

• Unregulated goods
• Non-compliant products
• Illegal substances

Examples

1. The TGA approved a new vaccine for distribution in Australia.
2. Before launching their product, the company had to consult with the TGA.
3. The TGA regulates all therapeutic goods to ensure public safety.
4. The TGA issues guidelines on the labeling of medicinal products.
5. The new drug was reviewed by the TGA for its safety profile.
6. The TGA monitors adverse reactions to medications.
7. Companies must submit their applications to the TGA for approval.
8. The TGA conducts inspections of manufacturing facilities.
9. The TGA collaborates with international regulatory bodies.
10. Patients can check the TGA's website for updates on approved therapies.
11. The TGA published a report on the effectiveness of a new treatment.
12. Manufacturers must comply with TGA regulations to sell their products.
13. The TGA evaluates clinical trial data before granting approval.
14. The TGA requires extensive testing for new drugs.
15. The TGA releases safety alerts regarding specific medications.
16. Researchers must report findings to the TGA during the trial phases.
17. The TGA is responsible for ensuring product quality.
18. The TGA provides educational resources for healthcare professionals.
19. The TGA advises on the use of complementary medicines.
20. The TGA works to protect public health.
21. The TGA issues recalls when products are found to be unsafe.
22. The TGA evaluates the risks associated with new medical devices.
23. The TGA conducts public consultations for feedback on new policies.
24. The TGA supports innovation in the therapeutic goods sector.
25. Patients often consult the TGA for medication information.
26. The TGA oversees the advertising of therapeutic products.
27. The TGA coordinates with health professionals regarding drug safety.
28. The TGA maintains a searchable database of medicines.
29. The TGA reviews product labeling for accuracy.
30. The TGA assesses the quality of imported therapeutic goods.
31. The TGA collaborates with the World Health Organization.
32. The TGA facilitates access to new treatments for patients.
33. The TGA provides guidance on clinical trial applications.
34. The TGA monitors the market for counterfeit products.
35. The TGA promotes transparency in the approval process.
36. The TGA issues licenses for manufacturers of therapeutic goods.
37. The TGA supports research into rare diseases.
38. The TGA reviews post-market surveillance data regularly.
39. The TGA encourages the reporting of side effects by consumers.
40. The TGA ensures that products meet stringent standards.
41. The TGA investigates complaints about therapeutic products.
42. The TGA collaborates with industry stakeholders for better practices.
43. The TGA advocates for patient safety in all its operations.
44. The TGA releases guidelines for the use of off-label medicines.
45. The TGA provides information on clinical trials to the public.
46. The TGA issues recommendations regarding vaccination uptake.
47. The TGA is involved in regulating blood products.
48. The TGA monitors the effectiveness of drugs post-approval.
49. The TGA emphasizes the importance of pharmacovigilance.
50. The TGA works to enhance the quality of therapeutic goods.
51. The TGA requires manufacturers to submit adverse event reports.
52. The TGA supports the use of technology in drug development.
53. The TGA ensures compliance with global standards.
54. The TGA recommends best practices for medication storage.
55. The TGA engages with the community on health issues.
56. The TGA provides a platform for reporting product issues.
57. The TGA reviews emerging health threats regularly.
58. The TGA participates in international drug regulatory forums.
59. The TGA issues safety warnings about specific medications.
60. The TGA works with manufacturers on product improvements.
61. The TGA clarifies regulations for new market entrants.
62. The TGA oversaw the approval of a groundbreaking therapy.
63. The TGA is committed to enhancing drug safety.
64. The TGA enforces regulations that protect consumers.
65. The TGA provides clear information on therapeutic goods.
66. The TGA collaborates with academic institutions for research.
67. The TGA offers workshops for industry training.
68. The TGA conducts assessments of clinical data.
69. The TGA is involved in public health campaigns.
70. The TGA champions the use of evidence-based practices.
71. The TGA is tasked with the regulation of herbal medicines.
72. The TGA requires ongoing education for medical professionals.
73. The TGA advises on drug interactions and contraindications.
74. The TGA works to streamline the approval process.
75. The TGA holds public forums to gather community input.
76. The TGA has a mandate to ensure therapeutic goods are safe.
77. The TGA provides updates on new regulations and policies.
78. The TGA is known for its rigorous assessment processes.
79. The TGA facilitates partnerships for research funding.
80. The TGA reviews existing products for continued compliance.
81. The TGA is involved in global health initiatives.
82. The TGA conducts training programs for health professionals.
83. The TGA issues guidelines for electronic submissions.
84. The TGA takes action against non-compliant products.
85. The TGA is committed to protecting public health and safety.
86. The TGA fosters collaboration among stakeholders.
87. The TGA is proactive in addressing emerging health issues.
88. The TGA manages the approval process for new technologies.
89. The TGA ensures that therapeutic goods are effective and safe.
90. The TGA provides resources for clinical trial sponsors.
91. The TGA evaluates the impact of therapeutic goods on public health.
92. The TGA issues certificates of compliance for manufacturers.
93. The TGA facilitates access to essential medicines.
94. The TGA works to mitigate risks associated with new therapies.
95. The TGA conducts assessments of manufacturing practices.
96. The TGA is responsible for regulating the importation of drugs.
97. The TGA provides technical assistance to manufacturers.
98. The TGA monitors the ongoing safety of approved products.
99. The TGA is a leader in drug regulation in the Asia-Pacific region.
100. The TGA commits to a transparent and accountable process.